Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium-L-Threonate for Menopausal Symptoms
NCT06959745Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- May 2025
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial in menopause comparing Magnesium-L-Threonate with Placebo (2 arms). Primary endpoint: Menopause Rating Scale at 8 weeks. Planned start May 2025; status: not yet recruiting.
02
Drugs
Magnesium L-threonate
03
Conditions
menopause
Beyond the preview
Go deeper on NCT06959745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06959745.